Our CEO, Aileen Lai, participated as a panel speaker alongside Nikita Gupta (Manager, Corporate Engagement Investment, SG Innovate), Akihiro Maeda (Head of Scouting, Medtech, BD & Licensing Department, TEIJIN PHARMA LIMITED), and Dr. Zheng Jye Ling (Chief Medical Informatics Officer, National University Hospital) on the topic 'Improving Patient Outcomes with Remote Monitoring and AI' on June 26, 2024.
Nikita Gupta quoted:
"I had the incredible opportunity to moderate my first panel last week on "Improving Patient Outcomes with Remote Monitoring and AI" at SGInnovate. It was truly an enlightening experience, featuring insights from a diverse group of experts—Akihiro Maeda (Teijin Pharma), Zheng Jye Ling (NUHS), and Aileen Lai (HealthBeats).
Here are my top 3 takeaways from our discussion:
đź“” Patient Literacy Matters: When developing remote monitoring solutions, it's crucial to design with patient literacy in mind. Ensuring that the software/hardware is intuitive and accessible can make a significant difference in adoption and compliance.
đź“Š Data Privacy and Ownership: As we develop more remote monitoring tools that collect a vast amount of patient data, addressing data privacy and ownership concerns is paramount. Patients need to feel secure and in control of their personal health information which has an added implication for technology providers to maintain security standards.
🤝 Collaboration is Key: Successful implementation requires a collaborative approach among tech companies, healthcare providers, and startups. Each brings unique strengths that, when unified, can drive accelerated advancements.
I thoroughly enjoyed moderating this panel and am grateful for the insights shared by our distinguished panelists. Looking forward to more opportunities to explore and contribute to this exciting field!"
SGInnovate is a government-owned innovation platform in Singapore centred on the development of deep technology. It was established in 2016 to consolidate innovation activities in Singapore. SGInnovate was founded to advance and scale deep technology products from Singapore.
Teijin Pharma Ltd. is a medical products manufacturer. The Company develops, manufactures, and sells pharmaceuticals and medical devices for bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. Teijin Pharma also provides related medical services and solutions.
To read more, please click here
Nikita Gupta quoted:
"I had the incredible opportunity to moderate my first panel last week on "Improving Patient Outcomes with Remote Monitoring and AI" at SGInnovate. It was truly an enlightening experience, featuring insights from a diverse group of experts—Akihiro Maeda (Teijin Pharma), Zheng Jye Ling (NUHS), and Aileen Lai (HealthBeats).
Here are my top 3 takeaways from our discussion:
đź“” Patient Literacy Matters: When developing remote monitoring solutions, it's crucial to design with patient literacy in mind. Ensuring that the software/hardware is intuitive and accessible can make a significant difference in adoption and compliance.
đź“Š Data Privacy and Ownership: As we develop more remote monitoring tools that collect a vast amount of patient data, addressing data privacy and ownership concerns is paramount. Patients need to feel secure and in control of their personal health information which has an added implication for technology providers to maintain security standards.
🤝 Collaboration is Key: Successful implementation requires a collaborative approach among tech companies, healthcare providers, and startups. Each brings unique strengths that, when unified, can drive accelerated advancements.
I thoroughly enjoyed moderating this panel and am grateful for the insights shared by our distinguished panelists. Looking forward to more opportunities to explore and contribute to this exciting field!"
SGInnovate is a government-owned innovation platform in Singapore centred on the development of deep technology. It was established in 2016 to consolidate innovation activities in Singapore. SGInnovate was founded to advance and scale deep technology products from Singapore.
Teijin Pharma Ltd. is a medical products manufacturer. The Company develops, manufactures, and sells pharmaceuticals and medical devices for bone and joint diseases, respiratory diseases, and cardiovascular and metabolic diseases. Teijin Pharma also provides related medical services and solutions.
To read more, please click here
